BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18455017)

  • 1. Liver transplantation at a university hospital, faculty of the medicine of Ribeirão Preto, University of São Paulo: results for the first 60 recipients.
    Castro-E-Silva O; Sankarankutty AK; Teixeira AC; Mente ED; Souza FF; Pacheco EG; Oliveira GR; Cagnolatti D; Correia RB; Campos W; Kemp R; Miranda A; Rondon LZ; Rizzo C; Mota GA; Martinelli AL; Ramalho FS; Ramalho LN; Zucoloto S
    Transplant Proc; 2008 Apr; 40(3):785-8. PubMed ID: 18455017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of waitlisted patients for liver transplantation at a liver transplantation unit in the city of Ribeirão Preto, São Paulo, Brazil, especially considering Child and Model for End Stage Liver Disease (MELD) scores.
    Teixeira AC; Souza FF; Sankarankutty AK; Martinelli AL; Castro E Silva O
    Transplant Proc; 2007 Mar; 39(2):387-9. PubMed ID: 17362738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation.
    Santoyo J; Suarez MA; Fernandez-Aguilar JL; Perez Daga JA; Sanchez-Perez B; Ramirez C; Aranda JM; Rodríguez-Canete A; Gonzalez-Sanchez A
    Transplant Proc; 2006 Oct; 38(8):2462-4. PubMed ID: 17097967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver transplantation for HCV cirrhosis at Karolinska University Hospital Huddinge, Stockholm.
    Gjertsen H; Weiland O; Oksanen A; Söderdahl G; Broomé U; Ericzon BG
    Transplant Proc; 2006 Oct; 38(8):2675-6. PubMed ID: 17098036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model for End-Stage Liver Disease (MELD) score system to evaluate patients with viral hepatitis on the waiting list: better than the Child-Turcotte-Pugh (CTP) system?
    Cuomo O; Perrella A; Arenga G
    Transplant Proc; 2008; 40(6):1906-9. PubMed ID: 18675085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the primary disease on rehabilitation results in the early postoperative period in patients after orthotopic liver transplantation.
    Rongies W; Stepniewska S; Golińska B; Kenczew-Kolanowska T; Dolecki W; Brudkowska A; Jakimowicz T; Federowicz M; Krawczyk M
    Transplant Proc; 2009 Oct; 41(8):3119-22. PubMed ID: 19857691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute renal failure in the first 100 orthotopic liver transplant patients in Southern Iran.
    Rais-Jalali GA; Sagheb MM; Daniali F; Behzadi S; Roozbeh J; Nikeghbalian S; Bahador A; Salahi H; Malek-Hosseini SA
    Exp Clin Transplant; 2007 Dec; 5(2):710-2. PubMed ID: 18194128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancers of new appearance in liver transplant recipients: incidence and evolution.
    Romero-Vargas ME; Flores-Cortés M; Valera Z; Gómez-Bravo MA; Barrera-Pulido L; Pareja-Ciuró F; Serrano Díez-Canedo J; García I; Bernardos A
    Transplant Proc; 2006 Oct; 38(8):2508-10. PubMed ID: 17097983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intestinal parasitosis and hepatic cirrhosis].
    Gaburri D; Gaburri AK; Hubner E; Lopes MH; Ribeiro AM; de Paulo GA; Pace FH; Gaburri PD; Ornellas AT; Ferreira JO; Chebli JM; Ferreira LE; de Souza AF
    Arq Gastroenterol; 1997; 34(1):7-12. PubMed ID: 9458954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morbidity and mortality in liver retransplantation.
    Alamo JM; Gómez MA; Pareja F; Martínez A; López F; Romero E; Barrera L; Serrano J; García I; Bernardos A
    Transplant Proc; 2006 Oct; 38(8):2475-7. PubMed ID: 17097972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retransplantation for end-stage liver disease: a single-center Asian experience.
    Sun CK; Chen CL; Concejero AM; Wang CC; Wang SH; Liu YW; Yang CH; Yong CC
    Transplant Proc; 2008 Oct; 40(8):2503-6. PubMed ID: 18929780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical value of the model for end-stage liver disease score in predicting the prognosis of liver transplantation in patients with end-stage liver disease].
    Sun J; Guo ZH; Lai TS; Tang YQ; Su L; Huo F; Wang SP; Pu MS; Wen Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1731-2, 1742. PubMed ID: 18819907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cirrhosis of mixed etiology (hepatitis C virus and alcohol): Posttransplantation outcome-Comparison with hepatitis C virus-related cirrhosis and alcoholic-related cirrhosis.
    Aguilera V; Berenguer M; Rubín A; San-Juan F; Rayón JM; Prieto M; Mir J
    Liver Transpl; 2009 Jan; 15(1):79-87. PubMed ID: 19109849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of liver transplantation outcome in patients with MELD Score > or = 30.
    Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Meira-Filho SP; Rezende MB; Paes AT; Afonso RC
    Transplant Proc; 2008 Apr; 40(3):797-9. PubMed ID: 18455020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of liver transplantation on autonomic dysfunction in patients with end-stage liver disease.
    Carey EJ; Gautam M; Ingall T; Douglas DD
    Liver Transpl; 2008 Feb; 14(2):235-9. PubMed ID: 18236403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The evolution of the role of liver transplantation in treating alcoholic cirrhosis in Greece.
    Imvrios G; Papanikolaou V; Tsoulfas G; Vasiliadis T; Kardassis D; Papagiannis A; Goulis I; Giakoustidis D; Antoniadis N; Fouzas I; Patsiaoura K; Ntinas A; Ouzounidis N; Vrochides D; Katsika E; Diplaris K; Miserlis G; Takoudas D
    Transplant Proc; 2008 Nov; 40(9):3189-90. PubMed ID: 19010229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.